Published in J Clin Endocrinol Metab on July 01, 1996
Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol (2010) 1.08
Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol (2008) 1.05
Radiation therapy in the management of pediatric craniopharyngiomas--a review. Childs Nerv Syst (2005) 1.05
Craniopharyngioma. Orphanet J Rare Dis (2007) 0.98
Treatment strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne) (2012) 0.97
Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy. Int J Pediatr Endocrinol (2011) 0.96
Craniopharyngioma in adults. Front Endocrinol (Lausanne) (2012) 0.93
Diagnostics, treatment, and follow-up in craniopharyngioma. Front Endocrinol (Lausanne) (2011) 0.87
Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst (2005) 0.85
Craniopharyngioma: the pendulum of surgical management. Childs Nerv Syst (2005) 0.85
Bariatric surgery in hypothalamic obesity. Front Endocrinol (Lausanne) (2012) 0.84
Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst (2010) 0.84
Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician. Childs Nerv Syst (2009) 0.83
Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma. J Neurooncol (2013) 0.82
Prevalence of obesity, hyperlipemia and insulin resistance in children with suprasellar brain tumors. Clin Pediatr Endocrinol (2007) 0.81
Craniopharyngioma in childhood: our evidence-based approach to management. Childs Nerv Syst (2005) 0.81
Functional capacity and body mass index in patients with sellar masses--cross-sectional study on 403 patients diagnosed during childhood and adolescence. Childs Nerv Syst (2005) 0.81
Obesity and craniopharyngioma. Ital J Pediatr (2011) 0.81
[Hypopituitarism]. Internist (Berl) (2004) 0.80
Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity. Obesity (Silver Spring) (2015) 0.80
Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention. J Clin Med (2015) 0.78
Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients. J Clin Med (2015) 0.77
Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. Eur J Pediatr (2010) 0.77
Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index. BMC Pediatr (2009) 0.77
Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities. Neurosurg Rev (2010) 0.76
Individualized treatment of craniopharyngioma in children: ways and means. Childs Nerv Syst (2005) 0.76
Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery. Pituitary (2012) 0.75
Investigating the Role of Hypothalamic Tumor Involvement in Sleep and Cognitive Outcomes Among Children Treated for Craniopharyngioma. J Pediatr Psychol (2016) 0.75
A reformed surgical treatment modality for children with giant cystic craniopharyngioma. Childs Nerv Syst (2017) 0.75
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet (1995) 4.01
Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet (1999) 3.72
Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet (1978) 3.59
Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J (1970) 3.38
Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ (1992) 3.27
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain (2000) 2.96
Growth curve for girls with Turner syndrome. Arch Dis Child (1985) 2.88
Population screening for congenital hypothyroidism. Br Med J (1980) 2.71
The stochastic nature of larval connectivity among nearshore marine populations. Proc Natl Acad Sci U S A (2008) 2.65
The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria. J Med Genet (1999) 2.63
A new stress-related syndrome of growth failure and hyperphagia in children, associated with reversibility of growth-hormone insufficiency. Lancet (1996) 2.58
Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet (1998) 2.58
Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain (1990) 2.53
Parathyroid venous sampling: anatomic considerations and results in 95 patients with primary hyperparathyroidism. Br J Radiol (1980) 2.29
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29
Estimating individual contributions to population growth: evolutionary fitness in ecological time. Proc Biol Sci (2006) 2.25
Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol (1991) 2.25
A simple oral test of growth-hormone secretion in children. Lancet (1968) 2.07
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet (2001) 2.05
Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain (1989) 2.00
Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain (1990) 2.00
Striking a balance between biodiversity conservation and socioeconomic viability in the design of marine protected areas. Conserv Biol (2008) 1.99
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ (1990) 1.99
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
Intracerebral haemorrhage. Accuracy of computerised transverse axial scanning in predicting the underlying aetiology. Lancet (1976) 1.98
A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann-Pick disease. A report of nine patients. Brain (1973) 1.94
Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol (1987) 1.93
Premature menarche without other evidence of precocious puberty. Arch Dis Child (1979) 1.89
Spinal epidural angiomatous malformations draining into intrathecal veins. Neuroradiology (1977) 1.88
Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology (1993) 1.87
Habitat structure and population persistence in an experimental community. Nature (2001) 1.86
Does computed tomography have a role in the evaluation of complicated acute bacterial meningitis in childhood? Dev Med Child Neurol (1992) 1.79
Single-species models for many-species food webs. Nature (2002) 1.72
Neurological abnormalities in patients treated for hypothyroidism from early life. Arch Dis Child (1978) 1.71
Growth, development, and reassessment of hypothyroid infants diagnosed by screening. Br Med J (Clin Res Ed) (1982) 1.70
Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child (1987) 1.62
Lessons from a case of kleeblattschädel. Case report. J Neurosurg (1995) 1.60
The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients. Q J Med (1990) 1.60
Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clin Endocrinol (Oxf) (1997) 1.55
The use of computed axial tomography (CAT) for the diagnosis and management of intracranial angiomas. Neuroradiology (1976) 1.54
Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet (2001) 1.54
Neuropathic vesicourethral dysfunction in children. A trial comparing clean intermittent catheterisation with manual expression combined with drug treatment. Br J Urol (1982) 1.53
Does the child with shunted hydrocephalus require long-term neurosurgical follow-up? Br J Neurosurg (1996) 1.53
Cranial MR imaging in Wilson's disease. AJR Am J Roentgenol (1996) 1.51
Position paper on the use of botulinum toxin in cerebral palsy. UK Botulinum Toxin and Cerebral Palsy Working Party. Arch Dis Child (1998) 1.51
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest (1995) 1.49
Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood. Arch Dis Child (1992) 1.49
Cerebral lymphoma: clinical radiological correlation. J Neurol Neurosurg Psychiatry (1982) 1.49
Effect of haematocrit on carotid stenosis and cerebral infarction. Lancet (1981) 1.48
A short water deprivation test incorporating urinary arginine vasopressin estimations for the investigation of posterior pituitary function in children. Acta Endocrinol (Copenh) (1988) 1.48
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology (1990) 1.47
A reappraisal of the CHARGE association. J Med Genet (1988) 1.46
Serum-insulin levels in children during glucose tolerance tests. Acta Paediatr Scand (1968) 1.46
Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology (1988) 1.46
Malignant melanoma and the central nervous system. A guide for classification based on the clinical findings. J Neurol Neurosurg Psychiatry (1976) 1.45
Histidinaemia. Study of relation between clinical and biological findings in 7 subjects. Arch Dis Child (1972) 1.41
The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain (1991) 1.41
Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet (1996) 1.41
Parietal foramina in Saethre-Chotzen syndrome. J Med Genet (1984) 1.40
Accurate placement of the atrial catheter in ventriculoatrial shunts. Technical note. J Neurosurg (1995) 1.40
Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndrome. Clin Endocrinol (Oxf) (1994) 1.39
Can computed tomography be relied upon to detect skull fractures? Clin Radiol (1989) 1.38
Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf) (1989) 1.38
Split cord malformations of the lumbar region. A model for the neurosurgical management of all types of 'occult' spinal dysraphism? Pediatr Neurosurg (1997) 1.38
Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg (1992) 1.38
Use of a commercial computer program for continuous audit of surgical complications. Ann R Coll Surg Engl (1996) 1.37
Intracranial neoplasms during the first year of life: analysis of one hundred consecutive cases. Neurosurgery (1984) 1.37
Oxandrolone in low dose for constitutional delay of growth and puberty in boys. Arch Dis Child (1985) 1.37
The 3-M syndrome. J Med Genet (1984) 1.37
Subcortical arteriosclerotic encephalopathy: a clinical and radiological investigation. J Neurol Neurosurg Psychiatry (1981) 1.36
The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth. J Pediatr Endocrinol Metab (2001) 1.35
Early detection of congenital hypothyroidism. Arch Dis Child (1977) 1.35
Cooperation between actin-binding proteins of invasive Salmonella: SipA potentiates SipC nucleation and bundling of actin. EMBO J (2001) 1.35
Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg (1996) 1.34
Maternal histidinaemia. Arch Dis Child (1971) 1.33
Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr (1999) 1.33
Transoral decompression and posterior fusion for rheumatoid atlanto-axial subluxation. J Bone Joint Surg Br (1986) 1.31
Symptomatic vertebral haemangiomas. Brain (1975) 1.31
Transcranial pulsed Doppler ultrasound findings in brain stem death. J Neurol Neurosurg Psychiatry (1987) 1.30
Radiological findings in neurosarcoidosis. Br J Radiol (1978) 1.29
Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry (1999) 1.29
Hypoplastic optic nerves and pituitary dysfunction. A spectrum of anatomical and endocrine abnormalities. Arch Dis Child (1984) 1.29
The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry (1988) 1.26
Subarachnoid haemorrhage of unknown aetiology. A clinical and radiological study of 51 cases. J Neurol Neurosurg Psychiatry (1977) 1.26
The long-term outlook for hydrocephalus in childhood. A ten-year cohort study of 155 patients. Pediatr Neurosurg (1997) 1.26
Management of choroid plexus tumours in children: 20 years experience at a single neurosurgical centre. Pediatr Neurosurg (2000) 1.25
Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia. Arch Dis Child (1972) 1.23
Language dysfunction in children with Rolandic epilepsy. Neuropediatrics (1998) 1.23
Enigma of raised intracranial pressure in patients with complex craniosynostosis: the role of abnormal intracranial venous drainage. J Neurosurg (2001) 1.23
Familial olivopontocerebellar atrophy with neonatal onset: a recessively inherited syndrome with systemic and biochemical abnormalities. J Neurol Neurosurg Psychiatry (1988) 1.22
Hydrocephalus and primary ciliary dyskinesia. Arch Dis Child (1984) 1.22
Cardiac rhabdomyomata as a marker for the antenatal detection of tuberous sclerosis. J Med Genet (1983) 1.22
High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. J Neurol Neurosurg Psychiatry (1992) 1.21
Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops. Eur J Pediatr (1994) 1.21